Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03903120 · ClinicalTrials.gov registry record · Phase 1
ASSIST: Treatment for Childhood Apraxia of Speech
A Phase 1 study of Childhood Apraxia of Speech, sponsored by Temple University.
- Active
- Registry status
- Phase 1
- Development phase
- 420
- Enrollment target
- 1
- Study location
NCT03903120 is a Phase 1 study of Childhood Apraxia of Speech that is active but no longer recruiting, run by Temple University. The registered enrollment target is 420 participants, above the 57-participant average among 3 other Childhood Apraxia of Speech trials with a reported enrollment target (637% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03903120, a Phase 1 study of Childhood Apraxia of Speech, is active but no longer recruiting, sponsored by Temple University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 420 participants
- Enrollment target
- 1
- Study location
Study Summary
Childhood apraxia of speech (CAS) is a pediatric motor speech disorder that impairs the planning of movements needed for intelligible speech. Children with CAS often show little or slow progress in standard speech therapy. This research is a Phase 1 study that tests initial efficacy and optimal parameters of a theoretically based integral stimulation treatment called ASSIST (Apraxia of Speech Systematic Integral Stimulation Treatment). In three small randomized group design studies, children (N=20 per study) receive 16 hours of individual ASSIST. The three studies systematically investigate treatment intensity (2 vs. 4 weeks) and two critical aspects of target selection: complexity (simple vs. complex target) and lexicality (words vs. nonwords). Each study also systematically examines the effect of treatment on functional outcome measures, including parent ratings of intelligibility and communicative participation, and objective intelligibility measures obtained from unfamiliar listeners.
Conditions Studied
Interventions
- BEHAVIORAL ASSIST
Study Locations (1)
Pennsylvania
- Temple University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2019-04-18 |
| Est. Completion | 2025-03-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03903120
The ClinicalTrials.gov registry entry for NCT03903120 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 57-participant average among 3 other Childhood Apraxia of Speech trials with a reported enrollment target (637% higher). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Childhood Apraxia of Speech appearing as the primary indexed condition, and to 1 intervention - of which ASSIST is the first listed.
NCT03903120 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03903120 about?
NCT03903120 is a clinical study titled "ASSIST: Treatment for Childhood Apraxia of Speech". Childhood apraxia of speech (CAS) is a pediatric motor speech disorder that impairs the planning of movements needed for intelligible speech. Children with CAS often show little or slow progress in standard speech therapy. This research is a Phase 1 study that tests initial efficacy and optimal para...
What is the current status of trial NCT03903120?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 420 participants. The study started on 2019-04-18. Estimated completion is 2025-03-31.
What conditions does trial NCT03903120 study?
This clinical trial studies the following conditions: Childhood Apraxia of Speech.
What interventions are being tested in trial NCT03903120?
The interventions under investigation include: ASSIST (BEHAVIORAL).
Who is sponsoring clinical trial NCT03903120?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03903120 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Apraxia of Speech
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.